John P. Clark
Comptroller/Controller/Auditor en IMMUNE PHARMACEUTICALS, INC. .
Perfil
John P.
Clark is currently working as Secretary & Controller at Immune Pharmaceuticals, Inc. He previously worked as Chief Financial Officer at Kogeto, Inc. from 2014 to 2015.
He completed his undergraduate degree from Montclair State University.
Cargos activos de John P. Clark
Empresas | Cargo | Inicio |
---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 20/11/2017 |
Antiguos cargos conocidos de John P. Clark.
Empresas | Cargo | Fin |
---|---|---|
KOGETO INC | Director Financiero/CFO | 01/08/2015 |
Formación de John P. Clark.
Montclair State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Kogeto, Inc.
Kogeto, Inc. Electronics/AppliancesConsumer Durables Kogeto, Inc. provided interactive and panoramic video capturing services. The company was founded by Jeff D. Glasse on January 10, 2014 and headquartered in New York, NY. | Consumer Durables |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- John P. Clark